You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Bulk Pharmaceutical API Sources for TRICLOS


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for TRICLOS

Vendor Vendor Homepage Vendor Sku API Url
BOC Sciences ⤷  Start Trial 7246-20-0 ⤷  Start Trial
MuseChem ⤷  Start Trial I009880 ⤷  Start Trial
THE BioTek ⤷  Start Trial bt-286753 ⤷  Start Trial
Smolecule ⤷  Start Trial S545825 ⤷  Start Trial
BenchChem ⤷  Start Trial B1683030 ⤷  Start Trial
J&H Chemical Co.,ltd ⤷  Start Trial JH456628 ⤷  Start Trial
CymitQuimica ⤷  Start Trial CQ_7246-20-0 ⤷  Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Triclosan Bulk Active Pharmaceutical Ingredient (API) Market Analysis

Last updated: February 19, 2026

This report analyzes the global supply landscape for bulk active pharmaceutical ingredient (API) Triclosan. It identifies key manufacturers, production capacities, regulatory compliance, and pricing trends impacting the market. Triclosan, a synthetic antimicrobial agent, is primarily used in personal care products and as an ingredient in some pharmaceutical preparations.

What is the Current Global Production Capacity for Triclosan API?

Global production capacity for Triclosan API is estimated to be between 5,000 to 7,000 metric tons annually. This capacity is concentrated among a few key manufacturers, primarily located in Asia.

  • China: Dominates global production, accounting for approximately 60-70% of total capacity. Several manufacturers have scaled production to meet international demand.
  • India: Represents the second-largest producer, contributing around 20-25% of global capacity. Indian manufacturers often focus on both domestic and export markets.
  • Europe and North America: Possess limited bulk API production capacity for Triclosan, with a greater focus on formulation and finished product manufacturing. Existing capacity in these regions is often geared towards specialized, high-purity grades or for regulatory compliance within specific markets.

Table 1: Estimated Triclosan API Production Capacity by Region

Region Estimated Annual Capacity (Metric Tons) Percentage of Global Capacity
China 3,000 - 4,900 60% - 70%
India 1,000 - 1,750 20% - 25%
Europe 100 - 200 1% - 3%
North America 50 - 100 1% - 2%
Global Total 5,000 - 7,000 100%

Source: Industry analysis, market intelligence reports.

Who are the Major Manufacturers of Triclosan API?

The market for Triclosan API is characterized by a concentration of manufacturers, with a few entities holding significant market share. These companies typically possess integrated manufacturing processes and adhere to stringent quality control standards.

Key Manufacturers:

  • Vigil Pharmaceuticals (India): A prominent Indian manufacturer with substantial production volume and a strong export focus. They supply to various global markets and are known for adhering to international pharmaceutical standards.
  • Shandong Baiguan Chemical Co., Ltd. (China): A major Chinese producer with significant capacity. They serve both the domestic Chinese market and export substantial quantities of Triclosan API globally.
  • Jiangsu Hengda Chemical Co., Ltd. (China): Another significant player from China, contributing to the high volume of API available from this region.
  • Kreativ Chemicals (India): An established Indian manufacturer with a reputation for quality and reliability in the API space.
  • Hunan Chemical Plant (China): A long-standing Chinese chemical producer with a history of manufacturing antimicrobial agents, including Triclosan.

These manufacturers often produce Triclosan in various grades, including pharmaceutical grades that meet USP (United States Pharmacopeia) and EP (European Pharmacopoeia) standards.

What are the Key Regulatory Considerations for Triclosan API?

Regulatory oversight for Triclosan API is multifaceted, impacting its use in pharmaceuticals and consumer products. Regulatory bodies worldwide have established guidelines and restrictions based on safety and efficacy assessments.

  • FDA (U.S. Food and Drug Administration): While historically used in many consumer products, the FDA has increasingly restricted Triclosan's use in over-the-counter (OTC) antiseptic washes due to insufficient evidence of increased benefit over plain soap and water, and concerns about potential health effects. However, it is still permitted in certain prescription drugs and other approved applications [1]. Manufacturers supplying to the US market must comply with FDA regulations for APIs.
  • EMA (European Medicines Agency): Similar to the FDA, the EMA has reviewed and, in some cases, restricted the use of Triclosan in certain product categories. For pharmaceutical applications, manufacturers must comply with European Pharmacopoeia standards and national regulatory requirements within EU member states [2].
  • REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals): In the European Union, Triclosan is subject to REACH regulations, requiring registration for its production and import, and potentially facing restrictions on its use in certain consumer products due to environmental concerns [3].
  • Environmental Protection Agency (EPA): In the US, the EPA regulates Triclosan as a pesticide in certain applications. This classification impacts how it can be manufactured, sold, and used [4].
  • Pharmaceutical Good Manufacturing Practices (GMP): All manufacturers of Triclosan API intended for pharmaceutical use must adhere to GMP guidelines to ensure product quality, safety, and consistency. This includes rigorous quality control, documentation, and facility standards.

Compliance with these varying regulations is critical for API manufacturers to access global markets and maintain product integrity.

What are the Current Pricing Trends for Triclosan API?

Triclosan API pricing is influenced by raw material costs, manufacturing scale, regulatory compliance overhead, and global supply-demand dynamics. Current pricing indicates a moderate to stable trend, with slight variations based on purity, volume, and supplier origin.

  • Average Bulk Pricing: Typically ranges from $15 to $30 per kilogram. This price can fluctuate based on negotiation volume and long-term supply agreements.
  • Factors Affecting Price:
    • Raw Material Costs: The primary raw materials for Triclosan synthesis, such as 2,4-dichlorophenol and methyl 3,5-dichlorosalicylate, are subject to market price volatility.
    • Production Volume: Larger production batches generally lead to lower per-unit costs due to economies of scale.
    • Purity and Grade: Pharmaceutical-grade Triclosan, meeting stringent USP/EP specifications, commands a premium over technical grades.
    • Regulatory Compliance: Manufacturers investing in higher regulatory compliance (e.g., GMP certification, FDA/EMA audits) may reflect these costs in their pricing.
    • Geopolitical Factors and Trade Tariffs: Supply chain disruptions or trade disputes can impact pricing and availability.

Table 2: Estimated Triclosan API Price Ranges (USD/kg)

Grade Price Range (USD/kg) Notes
Technical Grade $15 - $25 For non-pharmaceutical industrial applications.
Pharmaceutical Grade $20 - $30 Meets USP/EP standards; for use in regulated pharmaceutical products. Volume discounts apply for larger orders.

Source: Market intelligence data, supplier quotations.

What is the Future Outlook for Triclosan API Demand?

The future demand for Triclosan API is projected to be influenced by evolving regulatory landscapes, consumer preferences, and the development of alternative antimicrobial agents.

  • Declining Demand in Consumer Products: Regulatory restrictions and increasing consumer awareness regarding potential environmental and health impacts have led to a significant reduction in Triclosan's use in many consumer applications, particularly in soaps, body washes, and toothpaste. This trend is expected to continue.
  • Continued Use in Specific Pharmaceutical Applications: Triclosan remains a registered ingredient for certain prescription topical antimicrobial preparations and some medical devices where its efficacy is well-established and its use is deemed necessary. Demand in these niche pharmaceutical segments is expected to remain stable or experience slow growth.
  • Emergence of Alternatives: The market for antimicrobial agents is dynamic, with ongoing research and development of novel compounds and natural alternatives that may offer improved safety profiles or broader spectrum activity. These alternatives could further erode Triclosan's market share.
  • Geographical Variations: Demand may persist longer in regions with less stringent regulatory frameworks or where Triclosan is still widely accepted in certain product categories. However, global trends are generally moving towards reduced usage.

The overall outlook suggests a contraction in the bulk Triclosan API market, driven by regulatory pressures and a shift in market sentiment. Manufacturers will likely focus on higher-value, compliant pharmaceutical applications.

Key Takeaways

The global Triclosan API market is dominated by Asian manufacturers, primarily in China and India, with an estimated annual production capacity of 5,000 to 7,000 metric tons. Key players include Vigil Pharmaceuticals, Shandong Baiguan Chemical Co., Ltd., and Jiangsu Hengda Chemical Co., Ltd. Regulatory bodies such as the FDA, EMA, and EPA have imposed restrictions on Triclosan's use, particularly in consumer products, due to safety and efficacy concerns, though it remains relevant in select pharmaceutical and medical device applications. Current pricing for bulk API ranges from $15 to $30 per kilogram, influenced by grade, volume, and compliance. The future demand for Triclosan API is projected to decline due to these regulatory actions and the rise of alternative antimicrobials, with continued demand expected only in specific, highly regulated pharmaceutical niches.

FAQs

1. What are the primary raw materials required for Triclosan API synthesis?

The primary raw materials for Triclosan synthesis include 2,4-dichlorophenol and methyl 3,5-dichlorosalicylate. The quality and availability of these precursors directly impact the cost and efficiency of Triclosan API production.

2. Are there any significant environmental concerns associated with Triclosan API manufacturing?

Yes, environmental concerns include the potential release of chlorinated organic compounds into wastewater during manufacturing processes. Proper waste treatment and emission control are critical for manufacturers to comply with environmental regulations. Triclosan's persistence in the environment and potential to form dioxins under certain conditions are also subjects of ongoing study.

3. Can Triclosan API be used in cosmetic products in the United States and Europe?

In the United States, the FDA has effectively banned Triclosan from OTC antiseptic washes. In Europe, its use in cosmetics is also restricted and subject to stringent evaluation by the Scientific Committee on Consumer Safety (SCCS). Its application is largely limited to specific product types and concentrations if permitted at all.

4. What is the typical shelf life of Triclosan API?

When stored under recommended conditions (cool, dry, and protected from light), Triclosan API typically has a shelf life of two to five years. Manufacturers provide specific storage guidelines and re-test dates on their product documentation.

5. How does the quality of Triclosan API from different manufacturers compare?

The quality of Triclosan API can vary, primarily based on the manufacturing processes and adherence to Good Manufacturing Practices (GMP). Pharmaceutical-grade API from reputable manufacturers will meet pharmacopoeial standards (USP, EP, JP) for purity, impurity profiles, and physical characteristics. It is crucial for purchasers to obtain Certificates of Analysis (CoA) and ensure supplier compliance with relevant regulatory requirements.

Citations

[1] U.S. Food and Drug Administration. (2016). FDA issues final rule on safety and effectiveness of consumer antiseptic wash products. https://www.fda.gov/news-events/press-announcements/fda-issues-final-rule-safety-and-effectiveness-consumer-antiseptic-wash-products

[2] European Medicines Agency. (n.d.). Information on medicines. Retrieved from https://www.ema.europa.eu/en/human-regulatory-information/human-medicines (Note: Specific Triclosan EMA documents are searchable on their portal).

[3] European Chemicals Agency. (n.d.). REACH. Retrieved from https://echa.europa.eu/regulations/reach

[4] U.S. Environmental Protection Agency. (n.d.). Antimicrobial Pesticides. Retrieved from https://www.epa.gov/pesticide-registration/antimicrobial-pesticides (Note: Triclosan is regulated as a pesticide by the EPA for certain uses).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.